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Numerous in-vitro studies have suggested the possibility estrogen treatment; one pertinent feature is a marked rise that potential reactive intermediates, resulting from the metain the number of both secondary and tertiary lysosomes.
bolism of estrogens, may be the causative agents eliciting Data presented herein indicate that cathepsin D, an renal cell injury during chronic and prolonged exposure to estrogen-responsive lysosomal proteolytic enzyme, is estrogens (3-5). However, the relatively high estrogen concenincreased in the kidney following estrogen treatment in the trations (10-100 µM) required to generate significant quantities hamster. Three isoforms of cathepsin D were detected in of such estrogen metabolites in in-vitro assays (6-9) are estrogen-treated kidneys, 52, 31, and 27 kDa, the major inconsistent with the very low in-vivo estrogen levels found being 52 kDa. At 1 and 3 months of estrogen treatment, in the kidney (0.004 ng/mg protein) and serum (2.36 ng/ ml), a condition which yields essentially 100% renal tumor 52-kDa cathepsin D content increased 1.4-to 1.6-fold. These incidence (10).
changes coincided with a rise in renal estrogen receptor
Previous studies have extensively documented that the levels during the same estrogen treatment periods. More hamster kidney is a bona fide estrogen target tissue that pronounced rises in cathepsin D levels, 2.7-and 3.5-fold, possesses a functional estrogen receptor and inducible progeswere seen after 4 and 5 months of estrogen treatment, terone receptor as a result of estrogen treatment (11-13). respectively. A concomitant, 3.0-to 4.0-fold rise in estrogen Importantly, it has been shown that estrogens specifically receptor content was also observed. At 5 months of estradiol induce renal tubular cell proliferation in culture grown under or DES treatment, both 27-and 31-kDa isoforms were serum-free chemically-defined conditions at physiologic conpresent in hamster kidneys, in addition to the 52-kDa form.
centrations (1 nM) (14) .
Neither progesterone nor DHT treatment affected the
In estrogen receptor-positive breast cancer tissues, cathepsin untreated levels of cathepsin D. Interestingly, either con-D (EC 24.23.5), a lysosomal aspartyl endoprotease and comitant tamoxifen or DHT and estrogen treatment preestrogen-responsive proteolytic enzyme, is frequently elevated, vented the rise in cathepsin D and estrogen receptor content and is induced in hormone-dependent breast cancer cell lines observed after estrogen treatment alone. Primary estrogen- (15, 16) . Moreover, it has been suggested that, in breast cancer induced renal tumors and their metastases exhibited markcells, this secreted cathepsin D is involved in extracellular edly elevated levels of all three isoforms of cathepsin D.
matrix degradation and the metastatic spread of malignancy Immunohistochemical analysis of cathepsin D in kidney (17, 18) . Additionally, it has been reported that both cathepsin sections confirmed the Western blot findings. These data D and B exhibit proteolytic activity on basement membranes, suggest a novel role for estrogen-induced cathepsin D in possibly causing them to rupture (17, 19) , and that the 52 kDa the hamster kidney during tumorigenesis; that is, mediating cathepsin D precursor promotes breast cancer cell growth of renal tubular damage as a prelude to reparative cell estrogen-depleted MCF-7 cells (19) . proliferation, thus initiating a multi-step estrogen-driven
The data presented demonstrate that potent estrogens adminprocess which leads to renal tumor formation.
istered in vivo specifically elicit a marked rise in hamster kidney cathepsin D content, shown by immunohistochemical and Western blot analyses. Moreover, a concomitant rise in blotting, were determined at various monthly intervals of DES and implanted in the shoulder region as described earlier (20, 21) . Groups of treatment ( Figure 1 ). Three isoforms of cathepsin D with kDa six hamsters were treated with diethylstilbestrol (DES) for varying periods of values of 52, 31, and 27 were observed, the major isoform time (1-9 months), while similar groups of six hamsters were subjected to being 52 kDa. After 1 and 3 months of estrogen treatment, the following treatments for 5 months: i) 17β-estradiol (E 2 *); ii) estrone (E 1 ), iii) 17α-ethinylestradiol (EE); iv) progesterone (P); v) 5α-dehydrotestosterone small but consistent increases in 52 kDa cathepsin D content (DHT), vi) Tamoxifen (Tx); and vii) DES ϩ Tx. To maintain constant levels (1.4-to 1.6-fold) were observed, compared to age-matched of the compounds during treatment, additional pellets were implanted every untreated animals ( Figure 1A ). During the same estrogen 3 months. Age-matched untreated hamsters were used as controls. Renal treatment periods, similar increases in renal estrogen receptor tumors and their metastases were obtained from castrated male hamsters levels (1.6-to 1.8-fold) were found ( Figure 1B ). More protreated with DES for 8-9 months. The mean daily absorption, expressed in µg/day, of the compounds used was as follows: DES, 145 Ϯ 12; E 2 , 134 Ϯ 10; nounced rises in 52 kDa cathepsin D levels (2.7-and 3.5-fold) E 1, 104 Ϯ 9; EE, 154 Ϯ 9; Tx, 141 Ϯ 9; progesterone, 147 Ϯ 12; and DHT, were detected after 4 and 5 months of estrogen treatment, 121 Ϯ 9.
respectively. The 27 kDa cathepsin D isoform was present in The levels of cathepsin D and estrogen receptor were deter-1.5 mM EDTA, 1 mM DTT, 3% glycerol, 5 µg/ml leupeptin, 5 µg/ml aprotinin, 1 µg/ml pepstatin, and 100 µg/ml bacitracin. The homogenates were centrifuged mined after 5 months of in-vivo treatment with various estrogat 10 000 g for 15 min and then at 100 000 g for 1 h. Cytosolic protein ens, as well as P and DHT (Figure 2 ). The data show that concentrations were determined using the BCA method with BSA as standard DES and E 2 were the most effective estrogens, inducing 1.8-(Pierce, Rockford, IL). Aliquots (300 µl) were dispensed into Eppendorf tubes, and 2.0-fold increases in 52 kDa cathepsin D (Figure 2A ). In frozen, and stored at -80°C. addition, in E 2 -treated kidneys, both the 27 kDa and, to a Western blot analysis lesser extent, the 31 kDa isoforms were present. However, the Protein aliquots (100 µg) from the same treatment group were electrophoresed presence of these latter isoforms were found in lower amounts on a 4-20% gradient Tris-glycine SDS-PAGE (Novex, San Diego, CA) under in DES-treated kidneys; in particular, the 31 kDa-isoform was reducing conditions. Thereafter, proteins were transferred to nitrocellulose membranes which were treated with primary antibodies followed by secondary only faintly detected. A 2.0-and a 3.0-fold increase in renal antibodies conjugated with horseradish peroxidase. The immunoblots were estrogen receptor levels was also found after DES and E 2 visualized by chemiluminescence using Renaissance Reagent (Dupont, NEN, treatment, respectively ( Figure 2B ). The P-and DHT-treated metastases from 8 and 9 month DES-treated castrated male
Immunohistochemical analysis hamsters ( Figure 3) . As shown previously, all cathepsin D isoforms and estrogen receptor levels were elevated in the Both kidneys from groups of 3-5 hamsters treated with DES for 4 and 9 months, and from age-matched control animals were removed and examined.
kidney after 5 months of either DES or E 2 treatment alone.
Each kidney was cut in half and fixed in 4% buffered formaldehyde for However, the rise in 52 kDa cathepsin D and estrogen receptor 4 h at room temperature, followed by a rapid paraffin-embedding process. content seen at 5 months after DES treatment alone, was
Immunohistochemical localization of cathepsin D was performed using a prevented in hamsters receiving Tx ϩ DES treatment for the peroxidase anti-peroxidase (PAP) technique. Briefly, dewaxed kidney sections (6 µm) were treated with 4% H 2 O 2 in methanol for 20 min to block endogenous same period ( Figure 3A and B) . Interestingly, treatment with peroxidases, and the antigen retrieved by microwave heating at high power Tx alone, a partial estrogen agonist, did not elicit elevations in 100 mM citrate buffer pH 6.0 for 10 min (22) . The sections were then in either 52 kDa cathepsin D or estrogen receptor content, blocked with 6% normal goat serum in 1% BSA for 30 min and incubated both of which remained at essentially untreated renal levels.
with a polyclonal rabbit anti-cathepsin D antibody (DAKO Co., Carpinteria, CA), diluted 1:100, for 2 h at room temperature. Goat-anti-rabbit IgG (Sigma Similarly, when concomitantly administered with DES, DHT completely inhibited the rise in 52 kDa cathepsin D and Discussion estrogen receptor content induced by DES treatment alone Estrogen-mediated cytotoxicity found in various tissues follow-(data not shown).
ing chronic estrogen treatment is well documented, and the Both estrogen-induced primary renal tumors (Figures 1A subsequent pathologic changes have been described in detail and 3A) and their metastases ( Figure 3A ) exhibited appreciable (2, [23] [24] [25] . However, at present there is little understanding of levels of 52 and 27 kDa cathepsin D isoforms and estrogen the biochemical and cellular mechanism(s) involved in the receptor, when compared to 9 and 10 month age-matched cellular damage elicited by chronic exposure to these agents, untreated control levels. Although the 52 kDa cathepsin D conditions which frequently lead to a high incidence of tumor protein was the major isoform observed in primary hamster formation. renal neoplasms, substantial amounts of the 27 kDa isoform Like the breast and endometrium, the hamster kidney is an were also present. Moreover, lower levels of the 31 kDa estrogen-responsive and -dependent tissue. Therefore, it is not isoform were commonly seen in renal tumors and their surprising that the estrogen-treated kidney would respond to metastases ( Figures 1A and 3A) . many of the same genes as the more extensively studied target Localization of cathepsin D during estrogen-induced tumoritissues cited. In this regard, we have shown that c-myc, c-fos, genesis and c-jun, all early estrogen-response genes, are overexpressed in the kidney after only 4 months of estrogen treatment (26) . Cathepsin D was also assessed by immunohistochemical analysis in kidney sections from 4 month DES-treated hamsters, Interestingly, the overexpression of c-myc and c-fos are largely confined to early renal tumorous lesions and tumor foci (27) . age-matched untreated controls, and 9 month tumor-bearing DES-treated hamsters (Figure 4) . Staining was absent in kidney Cathepsin D is also considered an early estrogen-response gene since its expression appears to operate through an sections from 4 month untreated hamsters ( Figure 4A ). In contrast, marked cathepsin D activity was consistently found estrogen-responsive element (ERE) in the gene regulator region (28) , and is overexpressed in breast cancer. The gene product in the cytoplasm of renal proximal tubules after 4 months of estrogen treatment ( Figure 4B ). Cathepsin D staining in of cathepsin D is increased in breast cancer (15, 17, 18) and appears to be mediated by estrogens (15, 28) . It is noteworthy evidently damaged renal tubules of treated animals increased markedly in intensity at 9 months of DES treatment that the cathepsin D protein has also been found to be elevated in human squamous cervical, colon, and endometrial cancers, ( Figure 4C ). The staining in primary renal tumors induced by DES was intense and generally evenly distributed ( Figure 4D) . the last evidently mediated by progesterone (29) . In the hamster When compared to the levels observed in age-matched controls, only E 2 and DES induced appreciable increases (2.0-to 3.0-fold) in the levels of 52 kDa cathepsin D and estrogen receptor. P or DHT treatments for the same length of time had no effect on the levels of either protein. fication, and eventual renal tumor development (26, 27, 34) . 
